The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
2
No.
36
September 03, 1976Sep 03, 1976
Free
DOWNLOAD THE PDF

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

In Brief: Shingleton Chairs Cancer Control Committee; Joftes, Price Head Review, Organ Site Branches

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

Nine Cancer Act Changes Considered By NCAB Subcommittee

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account